| Patents for A61P 27 - Drugs for disorders of the senses (53,017) |
|---|
| 02/19/2003 | EP0950065B1 Peptide as diagnostic and therapeutic agent for autoimmune diseases |
| 02/19/2003 | EP0920425B1 Substituted 4-(1h-benzimidazol-2-yl-amino)piperidines useful for the treatment of allergic diseases |
| 02/19/2003 | CN1398265A 杂环酰胺衍生物 Heterocyclic amide derivatives |
| 02/19/2003 | CN1398264A 吲哚－3－基衍生物 Indol-3-yl derivative |
| 02/19/2003 | CN1398188A Boltuminum toxin pharmaceutical compsns |
| 02/19/2003 | CN1397335A Application of dandelion herb in preparing medicines |
| 02/19/2003 | CN1397284A Embedded nusk and its preparing process |
| 02/19/2003 | CN1397272A In-vivo gel preparatino able to be dropped in eyes and its preparing process |
| 02/18/2003 | US6521646 Integrin inhibitors |
| 02/18/2003 | US6521630 Tetrahydroquinazoline-2,4-diones and therapeutic uses thereof |
| 02/18/2003 | US6521606 Matrix metalloproteinase inhibitors |
| 02/18/2003 | US6521213 Administering mixtures of lipids, surfactants, dispersants, propellants and drugs such as antibiotics, bactericides, viricides and fungicides to the ears; protective coatings that reduce surface tension of the air/liquid interfaces |
| 02/18/2003 | CA2420042A1 Carboxylic acid derivatives, processes for the preparation thereof and pharmaceutical agents comprising the same as active ingredient |
| 02/13/2003 | WO2003012441A1 Method for detecting modulators of notch signalling |
| 02/13/2003 | WO2003012122A2 Crystallized structure of type iv collagen nc1 domain hexamer |
| 02/13/2003 | WO2003012111A2 Conjugates for the modulation of immune responses |
| 02/13/2003 | WO2003012105A2 Vegf isoform |
| 02/13/2003 | WO2003011899A2 Antigenic polypeptides |
| 02/13/2003 | WO2003011868A1 Thienopyrimidinediones and their use in the modulation of autoimmune disease |
| 02/13/2003 | WO2003011860A2 2-(3,5-BIS-TRIFLUOROMETHYL-PHENYL)-N-[6-(1,1-DIOXO-1λ6-THIOMORPHOLIN-4-YL)-4-(2-METHYL OR 4-FLUORO-2-METHYL SUBSTITUTED)PHENYL-PYRIDIN-3-YL]-N-METHYL-ISOBUTYRAMIDE |
| 02/13/2003 | WO2003011854A1 Pyrazole-derived kinase inhibitors and uses thereof |
| 02/13/2003 | WO2003011830A1 Heteroarylheteroalkylamine derivatives and their use as inhibitors of nitric oxide synthase |
| 02/13/2003 | WO2003011812A1 NOVEL AMINE DERIVATIVE HAVING HUMAN β-TRYPTASE INHIBITORY ACTIVITY AND DRUGS CONTAINING THE SAME |
| 02/13/2003 | WO2003011345A1 Lipid constructs as therapeutic and imaging agents |
| 02/13/2003 | WO2003011317A1 Modulators of notch signalling for use in immunotherapy |
| 02/13/2003 | WO2003011305A1 Composition of glycosaminoglycan and a peroxide for the treatment of dry eye |
| 02/13/2003 | WO2003011303A1 Dermal therapy using phosphate derivatives of electron transfer agents |
| 02/13/2003 | WO2003011299A2 Treatment of ocular hypertension and glaucoma |
| 02/13/2003 | WO2003011276A1 Nf?b inhibitor |
| 02/13/2003 | WO2003011268A1 (+)-cycloolivil as antioxidant obtained from stereospermum personatum |
| 02/13/2003 | WO2003011262A2 Use of 2-alkoxyphenyl-substituted imidazotriazinones for the treatment of diseases associated with cgmp regulated processes |
| 02/13/2003 | WO2003011252A1 Pharmaceutical composition comprising lipids comprising a polar and a nonpolar moiety |
| 02/13/2003 | WO2003011249A2 Ophthalmic composition containing n-acetylcysteine for the treat ment of dry-eye syndrome |
| 02/13/2003 | WO2003011178A2 Method for treatment of ocular hypertension and glaucoma |
| 02/13/2003 | WO2002096855A3 Anticholinergic compounds and methods of use |
| 02/13/2003 | WO2002076995A3 2-amino-propanol derivatives |
| 02/13/2003 | WO2002072011A3 Stabilized therapeutic and imaging agents |
| 02/13/2003 | WO2002060454B1 Use of dinucleoside polyphosphate to stimulate removal of fluid in retinal disorders |
| 02/13/2003 | WO2002055068A3 Cysteine for oral administration for dry eye treatment |
| 02/13/2003 | WO2002051434A3 Modulation of smr1-nep interactions in cns disorders giving rise to mental disorders |
| 02/13/2003 | WO2002046192A3 Thioether substituted imidazoquinolines |
| 02/13/2003 | WO2002038129A3 Delayed-release pharmaceutical formulations containing proinsulin c-peptide |
| 02/13/2003 | WO2002034283A3 Vegh inhibitors and their use |
| 02/13/2003 | WO2002015942A8 Method for the identification of agents that inhibit or promote cataracts and uses thereof |
| 02/13/2003 | US20030032834 Aminoalcohol derivatives |
| 02/13/2003 | US20030032803 Novel amide derivatives as inhibitors of matrix metalloproteinases, TNF-alpha, and aggrecanase |
| 02/13/2003 | US20030032665 Method of inhibiting matrix metalloproteinases |
| 02/13/2003 | US20030032663 Inhibition of the interaction of RAGE with its ligands; treatment acute and chronic inflammation, the development of diabetic late complications, Alzheimer's disease, erectile dysfunction, and tumor invasion and metastasis. |
| 02/13/2003 | US20030032656 2-Amino-nicotinamide derivatives and their use as vegf-receptor tyrosine kinase inhibitors |
| 02/13/2003 | US20030032652 Hydroxamic and carboxylic acid derivatives |
| 02/13/2003 | US20030032585 The use of trefoil factor 2 (TFF2) peptides increasing the viscosity of mucus layers in mammals |
| 02/13/2003 | US20030032179 Post-partum mammalian placenta, its use and placental stem cells therefrom |
| 02/13/2003 | US20030031718 Once-a-day, topical mixture of ketotifen, a chitosan, and a carrier to administer to the eye to treat allergies |
| 02/13/2003 | CA2808598A1 Antigenic polypeptides |
| 02/13/2003 | CA2456187A1 Pyrazole-derived kinase inhibitors and uses thereof |
| 02/13/2003 | CA2456096A1 Novel amine derivative having human .beta.-tryptase inhibitory activity and medecine containing the same |
| 02/13/2003 | CA2455598A1 Lipid constructs as therapeutic and imaging agents |
| 02/13/2003 | CA2455194A1 Vascular endothelial growth factor isoform having anti-angiogenic activity |
| 02/13/2003 | CA2454937A1 Modulators of notch signalling for use in immunotherapy |
| 02/13/2003 | CA2454918A1 Ophthalmic composition containing n-acetyl-cysteine for the treatment of dry-eye syndrome |
| 02/13/2003 | CA2454422A1 Treatment of ocular hypertension and glaucoma |
| 02/13/2003 | CA2454414A1 Use of 2-alkoxyphenyl-substituted imidazotriazinones |
| 02/13/2003 | CA2453937A1 Antigenic polypeptides |
| 02/13/2003 | CA2453274A1 Thienopyrimidinediones and their use in the modulation of autoimmune disease |
| 02/13/2003 | CA2451942A1 Crystallized structure of type iv collagen nc1 domain hexamer |
| 02/13/2003 | CA2451868A1 Pharmaceutical composition comprising lipids comprising a polar and a nonpolar moiety |
| 02/12/2003 | EP1283047A1 Method for producing a bioactive substance from blood serum |
| 02/12/2003 | EP1283045A1 Drug and food containing glucomannan for inhibiting IgE antibody |
| 02/12/2003 | EP1283043A1 Ophthalmic solution |
| 02/12/2003 | EP1283042A1 Aqueous liquid preparation |
| 02/12/2003 | EP1282684A2 Chondroitin synthase gene and methods of making and using same |
| 02/12/2003 | EP1282643A2 Anti-inflammatory compounds and uses thereof |
| 02/12/2003 | EP1282621A1 Novel vitronectin receptor antagonists |
| 02/12/2003 | EP1282614A1 Hydroxamic acid derivatives |
| 02/12/2003 | EP1282602A1 Propanoic acid derivatives as integrin receptor antagonists |
| 02/12/2003 | EP1282599A1 Disulfide derivatives useful for treating allergic diseases |
| 02/12/2003 | EP1282420A2 Halogenated 2-amino-3, 4 heptenoic acid derivatives useful as nitric oxide synthase inhibitors |
| 02/12/2003 | EP1282416A2 Dehydroascorbic acid formulations and uses thereof |
| 02/12/2003 | EP1282414A2 Felbamate derived compounds |
| 02/12/2003 | EP1282413A1 Halogenated 2-amino-5,6 heptenoic acid derivatives useful as nitric oxide synthase inhibitors |
| 02/12/2003 | EP1140984B1 Selective inhibitors of mmp-12 |
| 02/12/2003 | EP1054679B1 Use of surface active agent for the manufacture of a medicament for treatment of disorders of the middle ear |
| 02/12/2003 | EP0944601B1 Guanidinylamino heterocycle compounds useful as alpha-2 adrenoceptor agonists |
| 02/12/2003 | EP0862456A4 Enzymatic method and compositions for treating intravitreal hemorrhagic blood |
| 02/12/2003 | EP0614463B1 Angiostatic steroids |
| 02/12/2003 | CN1396930A Devivatives of partially desulphated glycosaminoglycans endowed with antiangiogenic activity and devoid of anticoagulating effect |
| 02/12/2003 | CN1396920A 1,3-disubstituted pyrrolidines as alpha-2-adrenoceptor antagonists |
| 02/12/2003 | CN1396912A 2-amino-nicotinamide derivative sand their use as VEGF-receptor tyrosine kinase inhibitors |
| 02/12/2003 | CN1396824A Eye drops |
| 02/12/2003 | CN1395964A Medical usage of simonder wood oil |
| 02/12/2003 | CN1395959A Eyedrops 'Yanbijing' |
| 02/11/2003 | US6518421 Process for the preparation of epothilone analogs |
| 02/11/2003 | US6518287 Substituted imidazoles as dual histamine H1 and H3 agonists or antagonists |
| 02/11/2003 | US6518277 Disrupting leukocyte function |
| 02/11/2003 | US6518264 For treatment/prevention of psychoses, other brain disorders, and cardiovascular disorders |
| 02/11/2003 | CA2205274C Novel 2,3 disubstituted-(5,6)-heteroarylfused-pyrimidine-4-ones |
| 02/06/2003 | WO2003010286A2 Nucleic acids, polypeptides, and methods for modulating apoptosis |
| 02/06/2003 | WO2003010164A1 Arylsulfonamide derivatives as c-jun-n-terminal kinases (jnk's) inhibitors |
| 02/06/2003 | WO2003010159A1 Piperidine derivatives as nmda receptor antagonists |
| 02/06/2003 | WO2003009867A1 Use of biologically active hiv-1 tat, fragments or derivates thereof, to target and/or to activate antigen-presenting cells, and/or to deliver cargo molecules for preventive or therapeutic vaccination and/or to treat other diseases |